During the past decade, Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "Sunovion" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Aspen Global Incorporated" with 1 trials sponsored and "Cardior Pharmaceuticals GmbH" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu" #1 collaborator was "ARMO BioSciences" with 1 trials as a collaborator and "Medtronic Poland Spółka z ograniczoną odpowiedzialnością" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu" are "Schizophrenia" (2 trials), "Acute Myocardial Infarction" (1 trials), "Angina Pectoris" (1 trials), "Bipolar I Depression" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu" in a lesser frequency.

Most popular intervention types in "Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu" are "Drug" (16 trials), "Other" (4 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "5-fluorouracil" (1 trials), "Andecaliximab" (1 trials), "Argatroban" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".